In a previous study, ARF6 was found to be a member of the Ras superfamily, which is induced by the KRAS-ERK1/2 pathway and promotes pancreatic cancer development by satisfying the increased energy needs and biosynthetic requirements of uncontrolled cell growth[13]. The gene discussed is KRAS; the disease is pancreatic neoplasm.